CELLINK Q5 2020 Results and MatTek Acquisition slide image

CELLINK Q5 2020 Results and MatTek Acquisition

The modern healthcare challenges CELLINK LIFE SCIENCES High costs and lengthy processes for drugs to reach patients. 9 out of 10 fail in clinical stages! HUMAN A life is lost every hour life is lost eve of the day due to lack of organ transplants Animal studies are poor indicators of success for human drug development © CELLINK 2021, All rights reserved.
View entire presentation